Glaukos: This ophthalmic medical technology and pharmaceutical company is witnessing strong demand across international glaucoma and corneal health franchises. Moreover, the launch of iStent ...

On its fourth-quarter earnings call, Glaukos highlighted the increasing adoption of iStent Infinite for glaucoma patients, particularly those unresponsive to other treatments. This growth has been ...

It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product ...

With over 20 years of experience, he has pioneered minimally invasive glaucoma surgeries (MIGS), including Trabectome, iStent and canaloplasty, transforming patient care. His research also focuses ...